A new high-impact journal for chemists marks a leading biomedical publisher's first foray into the physical sciences. Cell Press, the home of Cell, Neuron, and Current Biology, launches Chem this July and officially begins the expansion of its portfolio to meet the needs of the wider research community.
Prostate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.
The International Association for the Study of Lung Cancer praises the US Food and Drug Administration's decision to approve the first blood test to detect an oncogenic driver mutation in non-small cell lung cancer. This marks a significant step forward in lung cancer treatment. The cobas EGFR Mutation Test v2 detects epidermal growth factor receptor gene mutations and the FDA approved a blood-based companion diagnostic for the EGFR tyrosine kinase inhibitor erlotinib (Tarceva).
The multipurpose Neutron star Interior Composition Explorer (NICER) mission arrived at NASA's Kennedy Space Center in Cape Canaveral, Fla., on Wednesday, June 8. The forthcoming International Space Station (ISS) payload was transported from NASA's Goddard Space Flight Center in Greenbelt, Md., aboard a climate-controlled, air-suspension truck.
Kansas State University researchers have invented a new class of lasers. The energy-efficient lasers are portable; reach wavelengths that are invisible, requiring technology that is transparent at those wavelengths; and they have the potential to scale to high-powered versions.
Targeted training is necessary to help professionals tap into their medical and clinical expertise, while responding quickly and strategically to the ever-changing industry and regulatory trends. To address the competency and development needs arising from this evolving role, the Centre of Regulatory Excellence (CoRE) at Duke-NUS Medical School (Duke-NUS) and Janssen Asia Pacific, have formed the Joint Alliance Duke-NUS Education (JADE), a certificate program specializing in Medical Affairs.
Mayo Clinic announced the next major step in realizing Destination Medical Center's (DMC) vision of creating Discovery Square, a first-of-its-kind urban bioresearch campus that brings together renowned physicians, researchers, scientists and entrepreneurs to address unmet patient needs in an ultramodern setting for science innovation.
Bristol-Myers Squibb Company and the University of Texas MD Anderson Cancer Center today announced a new clinical research collaboration to evaluate innovative strategies for the potential use of Bristol-Myers Squibb's immuno-oncology agents Opdivo (nivolumab) and Yervoy (ipilimumab) to treat early and advanced-stage lung cancer patients.
A research team at Ulsan National Institute of Science and Technology (UNIST) has partnered with Power Plaza Co. Ltd., an electric vehicle manufacturer based in South Korea to make greener, lighter electric vehicles for urban mobility.
Life Extension™ joins with Insilico Medicine to develop advanced anti-aging technologies utilizing artificial intelligence.